Showing results (221-230 of 302) with videos related to

Sort By:
Pageof 31
International Journal of Chronic Obstructive Pulmonary Disease|May 20, 2025
Sputum Microbiome, Potentially Pathogenic Organisms, and Clinical Outcomes in Japanese Patients with COPD and Moderate Airflow Limitation: The Prospective AERIS-J StudyKazuhiro Yatera, Zhang Wang, Yoko Shibata, et al.
American Journal of Respiratory and Critical Care Medicine|January 19, 2008
Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in JapanYoshikazu Inoue, Bruce C Trapnell, Ryushi Tazawa, et al.
The New England Journal of Medicine|September 8, 2020
Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar ProteinosisBruce C Trapnell, Yoshikazu Inoue, Francesco Bonella, et al.
Chest|October 26, 2013
Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled granulocyte-macrophage colony-stimulating factor therapyRyushi Tazawa, Yoshikazu Inoue, Toru Arai, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 16, 2014
A mathematical model to predict protein wash out kinetics during whole-lung lavage in autoimmune pulmonary alveolar proteinosisKeiichi Akasaka, Takahiro Tanaka, Takashi Maruyama, et al.
The New England Journal of Medicine|October 1, 2019
Nintedanib in Progressive Fibrosing Interstitial Lung DiseasesKevin R Flaherty, Athol U Wells, Vincent Cottin, et al.
Science Translational Medicine|November 13, 2015
Modeling pulmonary alveolar microlithiasis by epithelial deletion of the Npt2b sodium phosphate cotransporter reveals putative biomarkers and strategies for treatmentAtsushi Saito, Nikolaos M Nikolaidis, Hassane Amlal, et al.
Scientific Reports|August 22, 2023
Cohort study to evaluate prognostic factors in idiopathic pulmonary fibrosis patients introduced to oxygen therapyKensuke Kataoka, Keishi Oda, Hajime Takizawa, et al.
The Lancet. Respiratory Medicine|November 21, 2017
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White PaperDavid A Lynch, Nicola Sverzellati, William D Travis, et al.
Annals of the American Thoracic Society|March 28, 2025
Intermittent versus Daily Therapy for Noncavitary Mycobacterium avium Complex Pulmonary Disease: An Open-label Randomized TrialTaku Nakagawa, Kohei Fujita, Mari Miki, et al.
Pageof 31